Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod in breast cancer skin metastases
NCT00899574Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- May 2009
- Primary completion
- Apr 2011
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imiquimod in breast cancer, sponsored by NYU Langone Health. Started May 2009; status: completed.
02
Drugs
imiquimod
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00899574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00899574.